Sarcopenia increases death risk in patients undergoing TAVI, finds study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2020-11-06 02:02 GMT   |   Update On 2020-11-06 04:38 GMT
Advertisement

Korea: Sarcopenia as measured by skeletal muscle index (SMI) significantly increases 1-year mortality risk in patients who underwent transcatheter aortic valve implantation (TAVI), suggests a recent study in the American Journal of Cardiology.

There is not much data on the association between sarcopenia and clinical outcomes in patients who underwent TAVI. Yong-Hoon Yoon, Chungnam National University School of Medicine, Sejong, Republic of Korea, and colleagues evaluated a total of 522 patients with severe aortic stenosis who underwent TAVI between March 2010 and November 2018 from the prospective ASAN-TAVI registry.

Advertisement

SMI was calculated using routine pre-TAVI computed tomography scan. SMI was defined as skeletal muscle area at the L3 level divided by height squared. The patients were classified into the gender-specific tertile groups of SMI. The patients' mean age was 79 years and 49% were men. Mean SMI values were 41.3 ± 6.7 cm 2/m 2 in men and 34.1 ± 6.5 cm 2/m 2 in women. 

Key findings of the study include:

  • The Kaplan–Meier estimates of all-cause mortality at 12 months were higher in the low-tertile group than in the mid- and high-tertile groups (15.5%, 7.1%, and 6.2%, respectively).
  • In multivariate analysis, low-tertile of SMI was an independent predictor of mortality (vs high-tertile of SMI, hazard ratio 2.69).
  • The all-cause mortality was substantially higher in the groups with high-surgical risk plus low SMI tertile.
  • The risk assessment with addition of SMI on conventional STS-PROM score was significantly improved by statistical measures of model reclassification and discrimination.

"The prognostic impact of SMI-measured sarcopenia was more prominent in patients with high surgical risks," concluded the authors. 

The study, "Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation," is published in the American Journal of Cardiology.

DOI: https://www.ajconline.org/article/S0002-9149(20)31145-0/fulltext


Tags:    
Article Source : American Journal of Cardiology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News